Skip to main content
SNAP Update and Resources Actualización y recursos de SNAP

On November 1, 2025, the requirements to receive and apply to the Supplemental Nutrition Assistance Program (SNAP) benefits have changed. To see the new policies to request SNAP benefits, click here and/or call 211 for SNAP assistance. Learn more

El 1 de noviembre de 2025, cambiaron los requisitos para recibir y aplicar para los beneficios del Programa de Asistencia Nutricional Suplementaria (SNAP, por sus siglas en inglés). Para consultar las nuevas políticas para aplicar para los beneficios de SNAP, haz clic aquí o llama al 211 para obtener ayuda de SNAP. Aprende Más

Transportation Update Actualización de transporte

Starting December 15, 2025, SafeRide Health will become the new provider for all member rides to doctor appointments and pharmacy visits. After this date, Texas Children’s Health Plan will no longer use MTM for Non Emergency Medical Transportation (NEMT) services.

Learn more here

For other questions, please call Member Services at the number on the back of your member ID card.

A partir del 15 de diciembre de 2025, SafeRide Health será el nuevo proveedor para todos los viajes de los miembros a citas médicas y visitas a la farmacia. Después de esta fecha, Texas Children’s Health Plan ya no usará MTM para los servicios de Transporte Médico No Urgente (NEMT).

Obtenga más información AQUI

Si tiene otras preguntas, llame a Servicios para Miembros al número que aparece en la parte posterior de su tarjeta de identificación del miembro.

Undescended Testicles and the Use of Ultrasound

Cryptorchidism or undescended testis (UDT) is the most common urological birth defect, occurring in 1 in 33 live male births. The most important reasons for surgical treatment of cryptorchidism include increased risks of testicular malignancy, infertility, testis torsion and/or inguinal hernia. The current standard of treatment for any UDT that fails to spontaneously descend by 6 months of age in the United States is orchidopexy (surgery to reposition the testis to the scrotum). Evaluation of UDT includes a thorough gestational history and a physical exam with a particular focus on noting the quality and position of the testes. Neither the American Academy of Pediatrics (AAP) or the American Urologic Association (AUA) recommend the use of ultrasound (US) or any other imaging modalities for evaluation of cryptorchidism. Indeed, both suggest not obtaining imaging for UDT. There are multiple factors that influence this recommendation, including accuracy of imaging, cost, availability of certain imaging modalities, rate of false positive, and need for anesthesia (for CT and MRI). While US is inexpensive, widely available, and does not require anesthesia, it is non-contributory in its routine use due to a low sensitivity (45%) and specificity (78%) in localizing the non-palpable testis. A prepubertal intraabdominal testis is typically not detected by US and maybe mistaken for a lymph node, which is similar in sonographic appearance. The ionizing radiation exposure and high costs associated with CT scan preclude its use. While MRI has a higher sensitivity and specificity for detection of intraabdominal testis, its use is deterred by high cost, limited availability and need for general anesthesia. Currently, no radiological test can be used to definitively conclude that a testis is absent. Hence, surgery in the form of diagnostic laparoscopy or open exploration is required for all non-palpable unilateral and many bilateral UDT patients. Accordingly, regardless of preoperative radiologic findings, these studies rarely assist in clinical decision making and may lead to misleading information (such as absence when actually present or vice versa). Primary Care Providers who are concerned about a potential diagnosis of undescended testicle should consider referral to urology or surgery for further evaluation. Abhishek Seth, MD, Assistant Professor, Urology and Pediatrics, Baylor College of Medicine Sources: Kolon TF, Herndon A, Baker LA, Baskin LS, Baxter CG, Cheng EY, Diaz M, Lee PA, Seashore CJ, Tasian G, Barthold J. “Evaluation and Treatment of Cryptorchidism: AUA Guideline” <www.auanet.org>